HB 3143 extends Oklahoma's moratorium on new medical marijuana business licenses (dispensaries, processors, growers) from August 1, 2026, to August 1, 2028. It requires existing license holders to get written approval from the Oklahoma Medical Marijuana Authority before transferring ownership, including submitting documentation to the Oklahoma State Bureau of Narcotics. Transfers must follow a 15-business-day timeline for license and registration changes, and applicants cannot submit transfer requests if disciplinary actions are pending. The bill also mandates that businesses provide a full inventory of all medical marijuana products during ownership changes and prohibits transfers without approval, with a 30-day window for pending applications to comply with new rules.
This bill requires Oklahoma hospitals to provide patients experiencing fetal death or miscarriage with a form explaining how to request official certificates (fetal death or stillbirth birth certificates) before discharge. Hospitals must also verbally inform patients about these certificate options. The State Department of Health must create and publish this standardized form online, including clear instructions and contact details for vital records. The law takes effect November 1, 2026, directly affecting hospitals and patients in Oklahoma facing these medical circumstances.
SB 1645 establishes new rules for auditing long-term care providers (like nursing homes and Medicaid home-care agencies) under Oklahoma's Medicaid program. It requires the Oklahoma Health Care Authority to give providers 1 week's notice before audits, limits audits to 50 claims or 0.25% of annual claims, and prohibits holding providers liable for simple clerical errors (like typos) as fraud. Providers must be allowed 60 days to correct claims after an audit, and recoupments (recovery of overpaid funds) can only apply to corrected claims, not original billing errors. The bill also creates a two-step appeals process, allowing providers to challenge audit results through the Authority and then to an administrative law judge.
SB 2007 requires pharmacy benefit managers (PBMs) in Oklahoma to pay administrative fees to pharmacies when they adjust reimbursement rates for the same drug within 30 days after a successful appeal. Specifically, if a PBM increases reimbursement based on an appeal but then lowers it again for the same drug within 30 days, the PBM must pay $100 immediately, escalating to $500 after 90 days or $1,000 after 180 days if unpaid. The bill directly affects pharmacies and PBMs by mandating these fee payments for disputed reimbursements, ensuring providers aren’t financially penalized for legitimate appeal outcomes. It also includes other provisions like weekly MAC price updates and requirements for PBMs to provide clear documentation during reimbursement disputes. The law takes effect November 1, 2026.
SB 1344 creates Oklahoma's Insulin Access and Affordability Program, administered by the State Department of Health, to increase access to affordable insulin for residents. The bill requires the Department to provide financial support to a nonprofit pharmaceutical manufacturer developing fast-acting biosimilar insulin, contingent on the manufacturer matching funds and agreeing to produce insulin at low cost without rebates (except as required by law). The agreement includes annual reporting on development progress and repayment terms if the insulin isn't produced and distributed as promised. This program directly affects Oklahoma residents needing insulin, public and private payors, and the specified nonprofit manufacturer.
SB 1134 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority for the 2026 fiscal year. The bill directly provides funding for the Authority to carry out its legal duties. It declares an emergency to allow immediate implementation upon passage. This is a procedural appropriations measure with no policy changes beyond the specified funding amount.
SB 1369 allocates $5.7 million from Oklahoma's general state funds to sustain and expand the state's 9-8-8 suicide and crisis hotline operations for the 2026-2027 fiscal year. This funding directly supports Oklahomans in mental health crises by ensuring access to the 9-8-8 hotline service. The bill provides specific funding to maintain current operations while increasing capacity for crisis response. It becomes effective July 1, 2026, and declares an emergency due to the urgent need for mental health support.
SB 1847 modifies Oklahoma's ADvantage Waiver Program, which provides Medicaid home- and community-based services. It creates an exception allowing individuals with cognitive impairments to qualify if they were already residing in an assisted living center contracted with the state when their impairment developed, and the center has a specific accommodation plan. This change directly affects adults with cognitive impairments who live in state-contracted assisted living facilities and developed their condition after moving in. The bill does not alter financial or age requirements but adjusts eligibility for this specific group. The exception applies to those meeting all three conditions outlined in the bill's new subsection B.
HB 2947 adds a new provider code in Oklahoma Medicaid for master's and doctoral-level behavioral health clinical interns. These interns - graduate students in nationally accredited programs - can provide services under the direct supervision of licensed behavioral health providers (like LPCs or LCSWs) while following all Medicaid documentation and training requirements. The bill directly affects interns seeking practical experience and licensed supervisors who will oversee their Medicaid-covered services. It expands Medicaid access to behavioral health care by formalizing intern participation in the state's Medicaid plan.
SB 2074 requires pharmacy benefit managers (PBMs) to accept all documentation from pharmacies when challenging reimbursement amounts and include specific details in appeal requests. If an appeal is approved, PBMs must adjust payments within 14 days and provide claim-level details. The bill applies to all PBMs working with Oklahoma pharmacies and covers disputes over reimbursement rates for prescription drugs. It aims to streamline the appeals process and prevent delays in payments to pharmacies.
